NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is a mitochondrial coenzyme central to redox biology, sirtuin activity, and DNA-repair pathways.
- Vial Size
- 500mg
- Molecular Weight
- 663.43 g/mol
- Half-life
- Short systemic; extended cellular pool effects
- Latest Lot Purity
- 99.69%
Mechanism of Action
NAD+ (Nicotinamide Adenine Dinucleotide) is a mitochondrial coenzyme central to redox biology, sirtuin activity, and DNA-repair pathways. Studied in longevity, energy metabolism, and cellular resilience research models.
Research Context
- Mitochondrial bioenergetics research
- Sirtuin pathway studies
- DNA repair and longevity models
- Cellular resilience assays
Lot NX-031 · Verified at 99.69%
Plasma Profile & Protocol
Modelled plasma concentration over time, reconstitution calculator, and a literature-derived research protocol for NAD+.
Illustrative Bateman model derived from published half-life and absorption data. For research-context visualisation only.
Solve for syringe units assuming a U-100 insulin syringe. Defaults seeded from the NAD+ monograph.
U-100 insulin syringe assumed (100 units = 1 mL). For research dosing visualisation only. Verify all dilutions independently.
- Typical Dose
- 100–300 mg
- Frequency
- 1–3× weekly
- Cycle Length
- Ongoing maintenance
- Route
- Subcutaneous or IM
Note ·Cellular pool effects extend well past plasma clearance.
Related Compounds
All compounds →
GHK-Cu
Copper tripeptide with strong regenerative and dermal research utility.
MOTS-C
Mitochondrial-derived peptide supporting metabolic resilience research.
For Research Use Only · This monograph summarises publicly available research literature for educational, in-vitro and laboratory research purposes only. Nexora Labs products are not drugs, food, supplements, or cosmetics, and are not intended to diagnose, treat, cure or prevent any condition.